The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models
Yan Ning, Melissa J Labonte, Wu Zhang, Pierre O Bohanes, Armin Gerger, Dongyun Yang, Leonor Benhaim, David Paez, David O Rosenberg, Kalyan C Nagulapalli Venkata, Stan G Louie, Nicos A Petasis, Robert D Ladner, Heinz-Josef Lenz, Melissa LaBonte Wilson
Dive into the research topics of 'The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models'. Together they form a unique fingerprint.